| Title |
Extended-Interval Dosing Strategy of Immune Checkpoint Inhibitors in Lung Cancer: Will it Outlast the COVID-19 Pandemic?
|
|---|---|
| Published in |
Frontiers in oncology, June 2020
|
| DOI | 10.3389/fonc.2020.01193 |
| Pubmed ID | |
| Authors |
Kartik Sehgal, Daniel B. Costa, Deepa Rangachari |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 5 | 31% |
| Italy | 1 | 6% |
| China | 1 | 6% |
| Switzerland | 1 | 6% |
| Colombia | 1 | 6% |
| United Kingdom | 1 | 6% |
| Unknown | 6 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 69% |
| Practitioners (doctors, other healthcare professionals) | 4 | 25% |
| Scientists | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 76 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 15 | 20% |
| Other | 11 | 14% |
| Student > Bachelor | 11 | 14% |
| Student > Ph. D. Student | 5 | 7% |
| Student > Master | 5 | 7% |
| Other | 9 | 12% |
| Unknown | 20 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 39% |
| Biochemistry, Genetics and Molecular Biology | 6 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 7% |
| Nursing and Health Professions | 3 | 4% |
| Veterinary Science and Veterinary Medicine | 2 | 3% |
| Other | 9 | 12% |
| Unknown | 21 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 February 2021.
All research outputs
#4,354,190
of 25,621,213 outputs
Outputs from Frontiers in oncology
#1,475
of 22,741 outputs
Outputs of similar age
#106,466
of 435,515 outputs
Outputs of similar age from Frontiers in oncology
#47
of 499 outputs
Altmetric has tracked 25,621,213 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,741 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,515 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 499 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.